Cargando…
A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens
Drug-resistant Neisseria gonorrhoeae is a serious global health concern. New drugs are needed that can overcome existing drug resistance and limit the development of new resistances. Here, we describe the small molecule tricyclic pyrimidoindole JSF-2414 [8-(6-fluoro-8-(methylamino)-2-((2-methylpyrim...
Autores principales: | Park, Steven, Russo, Riccardo, Westfall, Landon, Shrestha, Riju, Zimmerman, Matthew, Dartois, Veronique, Kurepina, Natalia, Kreiswirth, Barry, Singleton, Eric, Li, Shao-Gang, Mittal, Nisha, Ahn, Yong-Mo, Bilotta, Joseph, Connolly, Kristie L., Jerse, Ann E., Freundlich, Joel S., Perlin, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487510/ https://www.ncbi.nlm.nih.gov/pubmed/35972242 http://dx.doi.org/10.1128/aac.00414-22 |
Ejemplares similares
-
Novel phytochemical–antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR
por: Jayaraman, Premkumar, et al.
Publicado: (2013) -
Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection
por: Zhao, Xintong, et al.
Publicado: (2023) -
Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta
por: Nathania, Ignes, et al.
Publicado: (2022) -
Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
por: Tari, Leslie W., et al.
Publicado: (2013) -
Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China
por: Qian, Huimin, et al.
Publicado: (2020)